New study tests ulcer prevention in 7,000 people on common painkillers
NCT ID NCT07558707
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether the drug Fexuclue can prevent stomach ulcers in people who need to take NSAID pain relievers long-term. About 7,000 adults in Korea will take Fexuclue and report their stomach symptoms over 4 weeks. The goal is to see if the drug reduces ulcer symptoms in real-world use.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NSAID-INDUCED PEPTIC ULCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Multiple centers in Republic of Korea
Seoul, South Korea
More trials for these conditions
Other studies related to the condition(s) this trial covers.